(Q33864956)

29 July 2017

1 reference

title

Autoimmune diseases associated with drugs, chemicals and environmental factors (English)

1 reference

29 July 2017

D'Cruz D

1

1 reference

29 July 2017

1 March 2000

1 reference

29 July 2017

1 reference

29 July 2017

112-113

1 reference

29 July 2017

421-432

1 reference

Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Genetic susceptibility to scleroderma-like syndrome induced by vinyl chloride

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Drug-induced scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

HYDRALAZINE-INDUCED LUPUS: NO ASSOCIATION WITH HLA-DR4

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Cancer risk and mortality patterns among silicotic men in Sweden and Denmark.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Ultraviolet light-induced keratinocyte apoptosis: a potential mechanism for the induction of skin lesions and autoantibody production in LE.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Silica-dust-exposed mine workers with scleroderma (systemic sclerosis).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Allergic disorders in systemic vasculitis: a case-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with anti-thyroid drug treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Difficult asthma or Churg-Strauss syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Drug-induced vasculitides

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Hydralazine-pyrimidine interactions may explain hydralazine-induced lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

L-tryptophan and eosinophilia-myalgia syndrome in New Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Hepatitis C virus and mixed cryoglobulinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Connective tissue disease in southeastern Georgia: a case-control study of etiologic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Risk of connective-tissue diseases and other disorders after breast implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Self-reported breast implants and connective-tissue diseases in female health professionals. A retrospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Clinical follow-up and immunogenetic studies of 32 patients with eosinophilia-myalgia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Prevalence of symptoms of systemic lupus erythematosus (SLE) and of fluorescent antinuclear antibodies associated with chronic exposure to trichloroethylene and other chemicals in well water

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Clinical spectrum of connective tissue disease after cosmetic surgery. Observations on eighteen patients and a review of the Japanese literature

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Environmental factors predicting nephritis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Anti-topoisomerase I antibodies in silica-associated systemic sclerosis. A model for autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Bleomycin-induced cutaneous toxicity in the rat: analysis of histopathology and ultrastructure compared with progressive systemic sclerosis (scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Cutaneous complications of pentazocine injections

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Hair product use in systemic lupus erythematosus. A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Toxic oil syndrome and eosinophilia-myalgia syndrome: May 8-10, 1991, World Health Organization meeting report.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

3-(Phenylamino)alanine--a link between eosinophilia-myalgia syndrome and toxic oil syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Silicosis and fibrogenesis: Fact and artifact

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

CD4+ cells treated with DNA methylation inhibitors induce autologous B cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Lymphocyte function—associated antigen 1 overexpression and t cell autoreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

The association of progressive systemic sclerosis (scleroderma) with coal miners' pneumoconiosis and other forms of silicosis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Silicone breast implants and rheumatic disease. Clinical, immunologic, and epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Hair dye use and the risk of developing systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Allergic disorders in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Acetylator phenotype in patients with hydralazine-induced lupoid syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Environmentally-induced systemic sclerosis-like illness

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Environmental oestrogens--present understanding

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Clinical manifestations and course of vinyl chloride disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

SOLVENTS AND SCLERODERMA

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Immunological mechanisms in the pathogenesis of vinyl chloride disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Occupational acroosteolysis. Report of 31 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

Occupational scleroderma-like disorder occurring in men engaged in the polymerization of epoxy resins

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900220-9

7 January 2021

10.1016/S0378-4274(99)00220-9

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10720762